tiprankstipranks
Trevena Inc (TRVN)
NASDAQ:TRVN

Trevena Stock Analysis & Ratings

TRVN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.18 - $1.72
Previous Close$0.39
Volume1.26M
Average Volume (3M)1.80M
Market CapN/A
Enterprise ValueN/A
P/E Ratio-1.1
Beta0.38
Next EarningsAug 04, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score4


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

TRVN FAQ

What was Trevena’s price range in the past 12 months?
Trevena lowest stock price was $0.18 and its highest was $1.72 in the past 12 months.
    What is Trevena’s market cap?
    Currently, no data Available
    What is Trevena’s price target?
    The average price target for Trevena is $3.75. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
    The highest analyst price target is $4.00 ,the lowest forecast is $3.50. The average price target represents 861.54% Increase from the current price of $0.39.
      What do analysts say about Trevena?
      Trevena’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
        When is Trevena’s upcoming earnings report date?
        Trevena’s upcoming earnings report date is Aug 04, 2022 which is in 32 days.
          How were Trevena’s earnings last quarter?
          Currently, no data Available
          Is Trevena overvalued?
          According to Wall Street analysts Trevena’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Trevena pay dividends?
            Trevena does not currently pay dividends.
            What is Trevena’s EPS estimate?
            Trevena’s EPS estimate is -$0.1.
              How many shares outstanding does Trevena have?
              Trevena has 165,520,000 shares outstanding.
                What happened to Trevena’s price movement after its last earnings report?
                Currently, no data Available
                Which hedge fund is a major shareholder of Trevena?
                Among the largest hedge funds holding Trevena’s share is Moore Capital Management LP. It holds Trevena’s shares valued at N/A.

                  ---

                  Trevena Stock Analysis

                  The Trevena stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Trevena Inc

                  Trevena, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of innovative treatment options that target and treat diseases affecting the central nervous system, or CNS. The company product pipeline consists of Olinvo, TRV250, and TRV734. Trevena was founded by Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin and Erin Whalen on November 9, 2007 and is headquartered in Chesterbrook, PA.

                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Acelrx
                  Mesoblast
                  Pfizer
                  Amgen
                  Capricor Therapeutics

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis